Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Hankerchiefon Nov 02, 2018 8:30am

46 Views

Post# 28912920

RE:RE:RE:RE:RE:RE:Dr. Kamat Weighs in on Phase 2

Bencro,
With all due respect I don't think Perseus is a gimmick but I could be wrong. Seems like Wagner sunk a good bit of money in it. He just got frustrated over the expense and time for fda approval. Reading about their process seems to make some sense although I think their cure rates are < 20%. TLT appears to be much better which is why I want this to be successful.

bencro wrote: Hankerchief is just a goofy clown ...

The FDA never granted approval of the Perseus PCI drug.

Perseus is pure gimmick. You go scam people in fiscal heavens only when you're not competent enough to develop a therapy that is recognized by worldwide peers and published in elite peer-reviewed journals.

Why take a shortcut in the Caymans when you can take advantage of the network distribution of big pharmas that cover the world and have volume in terms of sales?

Amazing the clowns that we see on this board!
_______________

2013 ...

Thomas Wagner, Ph.D., said the offshore location is the best available option while the Food and Drug Administration decides if his treatment regimen will be approved for use in the United States.